Yahoo Web Search

Search results

  1. Aug 20, 2021 · According to new data from a large clinical trial, the Johnson & Johnson COVID-19 vaccine is up to 71% percent effective against hospitalization and 96% percent effective against death from the Delta variant. The clinical trial is the first real-world test of the vaccine’s efficacy against the highly transmissible variant.

    • Carla Delgado
  2. Sep 15, 2021 · Another study, which has not yet been peer-reviewed and only examined 27 people, suggests the J&J vaccine is 67 percent effective against the Delta variant.

  3. Aug 6, 2021 · The vaccine has an efficacy of up to 95 percent against death from the Delta variant, and up to 71 percent against hospitalization, the researchers reported. (The vaccine did...

    • Apoorva Mandavilli
  4. Jul 1, 2021 · The Johnson & Johnson coronavirus vaccine is effective against the highly contagious Delta variant, even eight months after inoculation, the company reported on Thursday — a finding...

    • Apoorva Mandavilli
  5. Jul 1, 2021 · These data showed that the Johnson & Johnson single-shot COVID-19 vaccine elicited neutralizing antibody activity against the Delta variant at an even higher level than what was recently observed for the Beta (B.1.351) variant in South Africa where high efficacy against severe/critical disease was demonstrated.

  6. Jul 2, 2021 · Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find. July 1, 20219:35 PM ET. By. Barbara Campbell. Enlarge this image. The Johnson & Johnson COVID-19...

  7. Jul 30, 2021 · A study published in the New England Journal of Medicine on July 21 by Public Health England, for example, found that after the two recommended doses, the effectiveness of the Pfizer/BioNTech...